drug discovery

Learn how cutting-edge strategies empower researchers to target undruggable proteins.

Learn how researchers take their drug discovery and development research to the next level with artificial intelligence.

In this webinar, Junguk Park and Vanda Lopes will discuss luciferase-based reporter cell lines that assess cytokine signaling, GPCR signaling, and enzyme activity.

Take a deep dive into the latest advances for gathering, integrating, and leveraging multiomics data for biomarker discovery.

Induced pluripotent stem cell-derived microglia generated with precision cell reprogramming technology can create more reliable in vitro assays.

Explore five tips for improving detection and reducing background noise with cell-based fluorescence measurements on microplate readers.

In his lab, Hashim Al-Hashimi investigated how RNA molecules move. Along the way, he founded a company.

High throughput screening (HTS) relies on liquid handling devices, robotics, plate readers, and data processing software to automatically test a large number of biological, genetic, chemical, or pharmacological samples. 

Properly optimizing data enhances AI training for accelerating novel biopharmaceutical discoveries. 

A combinatorial approach enabled high-throughput screening of protein libraries for desired target binding.

Good data management is the first step toward improving scientific outcomes with artificial intelligence and machine learning.

Learn how epithelial monolayer models help researchers discover effective therapies and biomarkers for inflammatory bowel diseases.

In this webinar, Patrick Schmidt will explore how to streamline CAR T cell product manufacturing processes for immunotherapy. 

Scientists need streamlined data storage and sharing to automate drug discovery workflows.

Discover tips for guiding drug development from discovery to the clinic.

Translational scientists employ surface plasmon resonance (SPR) to make informed decisions when choosing their lead antibody candidates. 

Cutting edge technology delivers cytokines with high purity, high bioactivity, high batch-to-batch consistency, and high stability.

Researchers use label-free surface plasmon resonance to measure affinity and binding kinetics in real time. 

Hundreds of bispecific antibodies are in development for imaging, diagnostic, and therapeutic applications against diseases such as cancer.